Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00558948 · ClinicalTrials.gov registry record

Musculoskeletal Outcomes After Bone Marrow Transplant

A clinical trial of Survivors of Bone Marrow Transplant and Autologous and Allogeneic, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Completed
Registry status
48
Enrollment target
1
Study location

NCT00558948 is a study of Survivors of Bone Marrow Transplant and Autologous and Allogeneic that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00558948, a study of Survivors of Bone Marrow Transplant and Autologous and Allogeneic, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

COMPLETED
Registry status
48 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate bone mineral density and muscle strength in survivors of bone marrow transplant. Association with age, type of transplant, steroids, years since transplant, body composition, endocrinopathies, radiation, quality of life and physical activity will be explored.

Study Locations (1)

Maryland

  • Johns Hopkins University, Bayview Campus - Baltimore

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2007-05
Est. Completion 2009-08

What the Registry Record Tells You About NCT00558948

The ClinicalTrials.gov registry entry for NCT00558948 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Survivors of Bone Marrow Transplant appearing as the primary indexed condition, and to 0 interventions.

NCT00558948 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00558948 about?

NCT00558948 is a clinical study titled "Musculoskeletal Outcomes After Bone Marrow Transplant". The purpose of the study is to evaluate bone mineral density and muscle strength in survivors of bone marrow transplant. Association with age, type of transplant, steroids, years since transplant, body composition, endocrinopathies, radiation, quality of life and physical activity will be explored.

What is the current status of trial NCT00558948?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2007-05. Estimated completion is 2009-08.

What conditions does trial NCT00558948 study?

This clinical trial studies the following conditions: Survivors of Bone Marrow Transplant, Autologous and Allogeneic.

Who is sponsoring clinical trial NCT00558948?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00558948 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.